SIA
AGN

Sit Investment Associates’s Allergan Inc AGN Stock Holding History

Sit Investment Associates’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-66,425
Closed -$14.1M – 460
2014
Q4 		$14.1M Sell
66,425
-1,450
-2% -$288K 0.23% 117
2014
Q3 		$12.1M Sell
67,875
-595
-0.9% -$98.8K 0.21% 119
2014
Q2 		$11.6M Sell
68,470
-2,245
-3% -$350K 0.2% 133
2014
Q1 		$8.78M Sell
70,715
-7,250
-9% -$883K 0.15% 151
2013
Q4 		$8.66M Sell
77,965
-1,750
-2% -$167K 0.15% 147
2013
Q3 		$7.21M Sell
79,715
-7,030
-8% -$631K 0.14% 160
2013
Q2 		$7.31M Buy
+86,745
New +$9M 0.15% 151

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 10.02% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Sit Investment Associates's AGN Position: Q1 2015 in Review

Sit Investment Associates sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 66,425 shares — an estimated $14.1M sold.

Sit Investment Associates first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $14.1M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Sit Investment Associates reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Sit Investment Associates sold 66,425 Allergan Inc shares in Q1 2015, an estimated $14.1M.
  • Sit Investment Associates first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Sit Investment Associates's Allergan Inc position peaked at $14.1M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Sit Investment Associates's 13F filing for Q1 2015, filed 30 Apr 2015.